Glipizide
Sulfonylureas
- Drug class
- Sulfonylureas
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 21
- FDA reports (12 mo)
- 1,539
Overview
Plain-language summary, compiled from the cited regulatory records
Glipizide is a medication belonging to the sulfonylurea class of drugs [1]. It is approved for use as a supplement to diet and exercise to help manage blood sugar levels in adults diagnosed with type 2 diabetes mellitus [1].
In the past 12 months, there have been 1539 adverse event reports associated with glipizide [2]. The most frequently reported adverse events include nausea, diarrhea, impaired gastric emptying, vomiting, and constipation [2]. Glipizide is available in the market under various brand names.
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 20 | May 7, 2026 |
| GB United Kingdom | MHRA | 1 | August 23, 2024 |
USUnited States· FDA
20 products
Uses
INDICATIONS AND USAGE
Glipizide Tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
How to take
GBUnited Kingdom· MHRA
1 product
Uses
Glipizide is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.
How to take
Drug interactions
Known interactions involving Glipizide. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 561. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 00729e82-150a-46… · revised March 19, 2026 [PDF]
- [2]MHRA (UK) · PL000571016 · revised August 23, 2024
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.